基于SEER数据库的胃瘤临床病理学特征和预后分析
Chenjian Qiu1, Chengru Hu2, Chengjie Lu3
1Department of Rehabilitation, Suzhou Ninth People's Hospital, The Affiliated Suzhou Bay Clinical College of Xuzhou Medical University, Suzhou, China.
PloS one
|December 17, 2025
概括
这项研究揭示了胃瘤 (Zollinger-Ellison综合征) 的特征和生存趋势. 胰腺胃瘤的结果比十二指肠胃瘤差,年龄和瘤大小会影响预后.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 流行病学 流行病学
背景情况:
- 胃瘤,通常与Zollinger-Ellison综合征相关,是罕见的,需要人口层面的数据对其特征.
- 对于胃瘤患者的临床病理特征和生存结果的了解有限.
研究的目的:
- 为了研究胃瘤的临床病理特征.
- 分析胃瘤患者的整体存活率 (OS) 和癌症特异性存活率 (CSS).
- 为了比较十二指肠和胰腺胃瘤之间的结果.
主要方法:
- 利用了监测,流行病学和最终结果 (SEER) 数据库,用于2000年至2020年期间诊断的患者.
- 用于临床病理学特征分析的Chi-square测试.
- 应用了Kaplan-Meier和Cox的比例危险模型来进行生存分析.
主要成果:
- 分析了160名患者;发病率在60-69岁年龄组达到顶峰.
- 胰腺 (52.5%) 和十二指肠 (32.5%) 是最常见的主要部位.
- 十二指肠胃瘤表现出更好的分化,早期阶段,更小的尺寸和更少的转移,与胰腺相比,与改善的OS和CSS相关.
- 肝脏是常见的转移部位;年龄和瘤大小被确定为危险因素.
结论:
- 十二指肠和胰腺的胃瘤表现出明显的临床病理特征.
- 十二指肠胃瘤与胰腺胃瘤相比,预后明显更好.
- N阶段,手术,化疗和瘤大小是影响胃瘤存活的关键因素.
更多相关视频
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
11.5K
05:16Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors
Published on: February 19, 2022
6.5K
相关概念视频
01:27Gastritis-I: Introduction and Types
2.1K
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
2.1K
01:21Cancer Survival Analysis
629
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
629